Key result
Graph neural networks fail to outperform standard voltage mapping or XGBoost for detecting abnormal ventricular potentials.
Why the study?
Manual annotation of abnormal ventricular potentials during substrate mapping for post-infarction ventricular tachycardia ablation is slow and operator dependent, motivating evaluation of whether a spatio-temporal graph convolutional network detects these potentials better than established alternatives.
Does a spatio-temporal graph convolutional network (ST-GCN) defined on the reconstructed left-ventricular surface detect abnormal ventricular potentials (AVPs) better than established alternatives (such as the conventional bipolar-voltage rule or gradient boosting on expert descriptors) in patients with post-infarction ventricular tachycardia?
Observational (n=9)
No
Does a spatio-temporal graph convolutional network (ST-GCN) defined on the reconstructed left-ventricular surface detect abnormal ventricular potentials (AVPs) better than established alternatives (such as the conventional bipolar-voltage rule or gradient boosting on expert descriptors) in patients with post-infarction ventricular tachycardia?
Complex spatio-temporal graph neural networks do not outperform simple clinical voltage rules or gradient boosting on expert features for identifying post-infarction VT ablation targets in the ARGO benchmark, largely because expert annotations in this dataset are heavily driven by bipolar signal amplitude.
Graph networks add no value over voltage or XGBoost for AVP detection; hypothesis-generating and should not yet change mapping practice.
Abnormal ventricular potentials (AVPs) recorded during substrate mapping guide catheter ablation in post-infarction ventricular tachycardia, and annotating them by hand is slow and operator dependent. We asked whether a spatio-temporal graph convolutional network (ST-GCN) defined on the reconstructed left-ventricular surface detects AVPs better than established alternatives. Using the ARGO dataset (nine patients, 1962 annotated bipolar electrograms, three independent electrophysiologists plus a consensus), we built one graph per patient with nodes at mapping sites and edges weighted by geodesic distance along the triangulated endocardial mesh. The network combined a dilated temporal encoder, Chebyshev graph convolutions, multi-head graph attention, and an auxiliary head regressing the distance to delivered radiofrequency lesions. Six comparators were trained under identical leave-one-patient-out cross-validation, among them the conventional bipolar-voltage rule (below 1.5 mV) and gradient boosting on 38 expert descriptors. Decision thresholds were estimated on pooled inner-validation patients only. Gradient boosting reached the highest AUC (0.973 +/- 0.033), ahead of the voltage rule (0.952 +/- 0.053) and the ST-GCN (0.942 +/- 0.052); no pairwise comparison favoured the ST-GCN (Holm-adjusted p > = 0.06). A 13-variant ablation showed that removing spatial message passing (0.949) or substituting Euclidean for geodesic edge weights (0.954) left performance unchanged, whereas removing the wideband amplitude channel lowered it to 0.921. Stratifying by voltage explains the pattern: below 0.5 mV every annotated electrogram was an AVP, above 1.5 mV 95.6% were physiological. In ARGO, expert AVP annotation is largely determined by bipolar amplitude, which limits how well the dataset can separate competing modelling strategies.
No takes yet. Share an insight, caveat, or question.
Amine BOUGARNE (2026) conducted an observational in Post-infarction ventricular tachycardia (n=9). Spatio-temporal graph convolutional network (ST-GCN) vs. Conventional bipolar-voltage rule (<1.5 mV) and gradient boosting (XGBoost) on 38 expert descriptors was evaluated on Detection of abnormal ventricular potentials (AVPs) measured by leave-one-patient-out cross-validation AUC-ROC (95% CI 0.888-0.977, p=1.000). Spatio-temporal graph convolutional networks achieved an AUC of 0.942 for detecting abnormal ventricular potentials, failing to outperform the <1.5 mV voltage rule (0.952) or XGBoost (0.973; p>=0.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: